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Abstract
Background: This study explored doctors’ understanding of ‘placebo’, mechanisms of action, perceptions about effectiveness and concerns 
about use in a Malaysian teaching hospital. Methods: A survey questionnaire. Results: Respondents were 76 doctors (response rate: 55%): 
52% were female, mean age was 32 years, and 61% were physicians/medical officers. Most (66.2%) never used a placebo. The main reason 
for use of placebos was for a possible psychological effect. Placebo use was considered unacceptable due to endangering of doctor-patient 
trust (59.2%) or patient deception (47.4%). Conclusion: Developing specific and professional standards and guidance on placebo use could 
help doctors to leverage the benefits of placebo use without endangering the doctor-patient relationship.
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Introduction
Recent surveys have shown that placebo use rates vary in-
ternationally. In 2013, 12% of general practitioners in the UK 
reported using a pure placebo at least once in their career, 
with 1% reporting use weekly. Almost all general practitioners 
(97%) reported using an impure placebo at least once in their 
career (77% weekly).1 Studies from Poland and the USA found 
that 79%  and 45% of doctors had used placebo as a treatment, 
respectively.2,3
Despite its success as a medical intervention for some pa-
tients,4-8 the ethical controversy around placebo use con-
tinues.9-14 A 2012 study found that placebo use was not ac-
ceptable for two main reasons: it threatens the doctor-patient 
relationship and it deceives the patient.15 The lack of a clear de-
finition of placebo adds to the confusion.1,16,17 Since Beecher’s 
1955 work “The Powerful Placebo”, the effect has been consi-
dered a scientific fact,18 and our understanding of the term has 
evolved from considering only ‘sugar pills’ to acknowledging 
that placebo includes any condition that simulates a therapeu-
tic environment. Placebo effects vary depending on not only 
whether or not a treatment is perceived to be administered, 
but how it is administered, and by whom.19 The potential be-
nefit that might be realised if judicious and appropriate use 
of placebo were employed is large. The objective of this study 
was to explore doctors’ understanding of the term placebo, 
mechanisms of action, its effectiveness, and concerns about 
use. 
Methods
A questionnaire (in English and Malay) examining attitudes 
to and experiences of using placebo was developed based on 
existing questionnaires.15,16 Qualified hospital physicians wor-
king in a teaching hospital in Sarawak were recruited in person 
over a 3-month period (January-March 2015). Written consent 
was obtained from all respondents. Out of an estimated 360 
doctors, 139 (38.6%) from 12 departments, excluding palliative 
care, were invited to participate.
Survey questions included demographic items, items concer-
ning the use of placebo, its effectiveness and opinions on use. 
Multiple responses were allowed for some items to capture as 
much information as possible. Respondents only responded to 
questions relevant to them. Respondents were also given a 
case in which a placebo was successful and asked to say why. 
Data was entered into SPSS for analysis. In the case of missing 
data for an item, the appropriate adjustments to the overall 
number of samples were made.
Ethical approval was granted by the Malaysian National Medical 
Research and Ethics Committee (NMRR-14-1155-21804(IIR)).
Results
A total of 76 doctors participated in the survey (response rate: 
54.7%). Mean age was 32.1 years (range: 24 to 52; standard devia-
tion [SD]: 5.7), and 38 (52.1%) were female. Twelve (15.8%) were 
junior doctors, 43 (56.6%) were physicians, and 16 (21.1%) were 
specialists. Average number of years of practice was 6.3 years 
(range: 0.1 to 27; SD: 5.4). Mean number of patients treated per 
week was 74.29 (range: 6 to 200, SD: 50.4). The main reason for 
non-participation in the study was the lack of time.
Of the definitions given, “placebo is an intervention that is not 
expected to have an effect through a known physiological method” 
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was most endorsed (49.3%), followed by “placebo is an interven-
tion that is not considered to have any specific effect on the condi-
tion treated but with a possible unspecific effect” (38.4%). 
The reasons for placebo use, what was used, when and how are 
presented in Table 1. Most doctors, (n=49, 66.2%) never used pla-
cebo, while 20.3% did so once a year on average and 2.7% daily. 
There were no significant differences in placebo use by gender, age 
or experience. Of those who used placebo (n=25), 71.9% used it for 
its possible psychological treatment effect and 28.1% for constant-
ly complaining patients or to bridge a difficult treatment situation. 
Almost one third (31%) used a placebo as a diagnostic tool. 
Placebo Use n (%)
What motivated you to prescribe or administer a placebo?
Because of a possible psychological treatment effect 23 (71.9)
For constantly complaining patients, to bridge a difﬁcult treatment situation 9 (28.1)
Because the patient was expecting a therapy 8 (25.0)
To be able to still offer a treatment option to patients with untreatable, incurable disease 5 (15.6)
Have you ever prescribed or given the following form(s) of treatment in situations without demonstrated or expected clinical efficacy?
Saline injection 21 (65.6)
Vitamins 16 (50.0)
Placebo pills 6 (18.8)
Minerals and trace elements 4 (12.5)
Massages 4 (12.5)
Sub therapeutic doses 4 (12.5)
Antibiotics 3 (9.4)
Herbal supplements 2 (6.3)
Acupuncture 1 (3.1)
Ibuprofen 1 (3.1)
Sugar pills 0 (0.0)
In which of the following situations have you prescribed or administered a placebo?
To calm a patient 15 (51.7)
To mollify a complaining patient 9 (31.0)
As a diagnostic tool 9 (31.0)
Instead of medication, when using that medicine is not justified 8 (27.6)
As a treatment for a nonspecific symptom 6 (20.7)
As a supplement to medication 2 (6.9)
To control pain (including in the context of patient controlled analgesia) 2 (6.9)
Instead of a medication in order to buy time between one dose and the next of the medication 1 (3.4)
How did you inform your patients?
It is a substance that may help and will not harm 19 (54.3)
It is a medication 13 (37.1)
It is a potentially beneficial medicine or treatment not typically used for their condition 7 (20.0)
I said nothing 6 (17.1)
It is a medicine with no specific effect 4 (11.4)
It is a placebo 3 (8.6)
This therapy has helped many other patients 2 (5.7)
This is a highly effective drug or therapy 1 (2.9)
This treatment promotes self-healing or the healing process 1 (2.9)
I said what effect is expected from the therapy 1 (2.9)
This is a treatment without pharmacological or physical effect for your condition 0 (0.0)
When you use placebo, it is
Sometimes effective 22 (66.7)
Usually effective 7 (21.2)
I do not know if it is effective 3 (9.1)
Never effective 1 (3.0)
Table 1. Placebo Use among Doctors at a Teaching Hospital in Malaysia
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Placebo users favoured saline injection (65.6%) and vitamins 
(50%). Most rejected the use of antibiotics (68.6%) and ibuprofen 
(57.1%) as placebos. Placebo use was most frequently thought to 
be acceptable if used for its psychological effect (74.3%) or becau-
se it does not cause harm (34.3%). The most common reasons for 
placebo use being unacceptable was the possibility of endange-
ring the trust between doctor and patient (59.2%) and deception 
of patient (47.4%). Respondents thought that placebo use could 
be permitted if research (59.5%) or excellence in the department 
(24.3%) supports its efficacy. More than 10% of respondents thou-
ght placebo use should be prohibited.
When prescribing placebo, 54.3% of the doctors informed the pa-
tient that “it is a substance that may help and will not harm”, 
37.1% informed patients that “it is a medication”, and 17.1% said 
nothing. The majority (87.9%) of prescribing doctors observed pla-
cebo was sometimes or usually effective. For the case, most doc-
tors (73.3%) thought that improvements in pain experienced were 
because the pain was psychogenic (n=55, 73.3%).
Discussion
The study provides information about doctors’ perceptions of what 
a placebo is, its use, and attitudes towards placebo usage in a 
Malaysian context. Most respondents had not prescribed a pla-
cebo (66.2%). Although this is consistent with a recent Canadian 
study (23% used placebo),20 it is inconsistent with other surveys 
reporting higher use.1,2 The reasons cited by doctors for non-use 
are consistent with other studies in which respondents were con-
cerned about endangering trust or withholding information des-
pite the prevalence of a paternalistic doctor-patient relationship 
in Malaysia.6 Perhaps the move towards evidence-based practice 
is significant as most doctors in this study felt that placebo use 
should only be permitted if supported by research. Most doctors 
reported prescribing placebo for possible psychological effects and 
in situations to calm patients. This may be because most doctors 
agreed that the mechanism of placebo is mostly psychological. 
The placebo effect is influenced by a patient’s positive expecta-
tion following a clinical encounter,21 as highlighted in open/hidden 
studies where a placebo effect is documented but no ‘placebo’ is 
used.22 Over half of the placebo users in the current study infor-
med their patients that the placebo was a substance ‘that may 
help’ while others referred to it as ’a medication’. Such language 
is likely to foster an expectation of beneficial effect in the patient. 
The power of expectation is very important in the therapeutic envi-
ronment, yet the medical profession may underutilize this poten-
tially effective tool as a result of poorly understanding it. 
Almost a third of doctors reported using placebo as a diagnos-
tic tool to distinguish between a genuine and imaginary symp-
tom. It is acknowledged that use of placebos may result in an 
improvement in physical symptoms; hence the use of placebo in 
such a diagnostic capacity is, at best, ineffectual as physiological 
effects may occur. At worst it is dangerous as it may result in the 
non-treatment of genuine disorders and belies the effectiveness 
of placebo. 
Most doctors surveyed thought the mechanism of action of pla-
cebo was psychological and felt that improvements in pain expe-
rienced as a result of placebo administration were because the 
pain had no organic cause and was psychogenic. These results 
highlight a lack of understanding of the physiological effects of 
placebo. While there appears to be an awareness of the power 
of expectation, when presented with a case of effective placebo 
treatment doctors appear somewhat reluctant to acknowledge the 
physiological power of placebo.
 
It has been suggested that difficulty in explaining to patients that 
a treatment may not help may reduce the potential placebo effect, 
leading doctors to use some form of deception such as not telling 
the patient directly that they are using a placebo.23,24 Respondents’ 
perceptions regarding placebo effectiveness were ambivalent. Whi-
le some doctors agreed that placebos are effective, most chose a 
neutral stance. There appears to be gaps in doctors’ knowledge 
regarding placebos, how they work, and how they may be used, 
likely to limit the discussion of treatment options not specifically 
designed for the patient’s complaint. 
Limitations to this study included the small sample size and the 
limited setting of a single hospital (so results may not be genera-
lizable to other hospitals in Malaysia). Small numbers of doctors 
were recruited from each department, hence the doctors were con-
sidered as a homogenous group and not representative of their in-
dividual departments. Further research is warranted into differing 
attitudes to placebo use among doctors specialising in areas such 
as pain management. The survey relied on doctors recalling how 
frequently they had used placebos in the past. Thus, we cannot 
determine the actual frequency of use. Strengths of this study 
include the use of a purpose designed questionnaire available in 
both English and Bahasa Malaysia. This study also contributes to 
the knowledge of attitudes to placebo use among healthcare pro-
fessionals in Malaysia, an area which has been understudied to 
date. 
The majority of doctors surveyed do not use placebos. A growing 
body of evidence on the usefulness of placebo raises the ques-
tion of whether use should be recommended. This raises ethical 
challenges. Agreement on the range of interventions that are con-
sidered suitable to be used as placebo, and in what situations, 
would bring clarity to the discussion. A clear definition is needed 
to prevent conceptual confusion and further research should ex-
plore how doctors might harness the power of placebo without en-
dangering the very relationship that may contribute to the effect. 
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